bleeding for 3 months. Bleeding was intermittent, small in amount, painless, bright red drops of blood after defecation. He had h/o of polypectomy. Seven days after polypectomy bleeding restarted with same character.Patient had no historyof fever, abdominal pain, joint pain, constipation, rash, abnormal bleeding tendency, visual disturbances. He had no family h/o of such type of illness. He was delivered by LUCS with birth weight of 5 kg. He had h/o of delayed milestone of development. General physical examination revealed mild pallor, normal oral cavity. There was no jaundice, cyanosis, edema, thyromegaly, lymphadenopathy, clubbing, or scoliosis. Vitals within normal limit. Skin survey normal. Anthropometric examination revealed macrocephaly with head circumference of 59 cm (>97 percentile), height 139 cm (on 25 th centile), weight 26 kg (between 5 th & 3 rd centile ( Figure 1 ). Multiple subcutaneous masses were present on the left lower abdomen measuring about 11cm × 9cm, soft in consistency ( Figure 2 ). Other systemic examination revealed normal findings. Hematological and biochemical parameters were within normal limit. Colonoscopy revealed polyp in transverse colon ( Figure 3 ) & histopathology showed cystically dilated glands with chronic inflammation, features were consistent with hamartomatous polyp (Figure 4) . Patient also had intellectual impairment on WISK-R assessment. There is cryptorchidism on genitalia examination.
On the basis of clinical features of macrocephaly, lipomas, intellectual impairment, cryptorchidism and intestinal hamartomatous polyp; a diagnosis of Bannayan-Rilay-Ruvalcaba Syndrome (BRRS) was made. PTEN gene mutation analysis could not be done.
Discussion:
Bannayan-Riley-Ruvalcaba syndrome (BRRS) is a rare hamartomatous polyposis syndrome. This syndrome was originally described separately by Riley and Smith, Bannayan and Zonana, and Ruvalcaba, Myher, and Smith 4 . In 1990, Cohen used term BRRS to unify these as a single entity. DiLiberti proposed a new nomenclature of multiple syndromes that are caused by mutations in the PTEN gene. He proposed that it be called the PTEN MATCHS syndrome; MATCHS was derived from macrocephaly, autosomal dominant, thyroid disease, cancer, hamartomata, and skin abnormalities. Marsh et al. (1999) suggested that the spectrum of disorders maybe known as PTEN hamartoma tumor syndrome (PHTS). 
